Pictet Asset Management
VKTX icon

Pictet Asset Management’s Viking Therapeutics VKTX Stock Holding History

Pictet Asset Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.6M Sell
682,909
-13,392
-2% -$433K 0.03% 470
2026
Q1 		$22.7M Sell
696,301
-56,431
-7% -$1.81M 0.02% 476
2025
Q4 		$26.5M Sell
752,732
-443,573
-37% -$15.7M 0.03% 459
2025
Q3 		$31.4M Sell
1,196,305
-720,569
-38% -$21.5M 0.03% 420
2025
Q2 		$50.8M Sell
1,916,874
-4,562
-0.2% -$120K 0.05% 313
2025
Q1 		$46.4M Buy
1,921,436
+684,343
+55% +$21.6M 0.05% 316
2024
Q4 		$49.8M Sell
1,237,093
-124,417
-9% -$7.09M 0.05% 298
2024
Q3 		$86.2M Sell
1,361,510
-19,864
-1% -$1.17M 0.09% 220
2024
Q2 		$73.2M Buy
1,381,374
+3,338
+0.2% +$219K 0.08% 231
2024
Q1 		$113M Buy
1,378,036
+683,312
+98% +$30.4M 0.12% 191
2023
Q4 		$12.9M Buy
694,724
+683,355
+6,011% +$8.94M 0.01% 588
2023
Q3 		$126K Buy
+11,369
New +$163K ﹤0.01% 1788

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Pictet Asset Management's VKTX Position: Q2 2026 in Review

Pictet Asset Management reduced its Viking Therapeutics (VKTX) stake by 1.9% in Q2 2026, selling an estimated $433K and leaving 682,909 shares worth $26.6M. The position accounts for 0.03% of the portfolio, ranked #470.

Pictet Asset Management first reported a position in VKTX in Q3 2023 and has held it in 12 quarters since. The position peaked at $113M in Q1 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Pictet Asset Management held 682,909 shares of Viking Therapeutics worth $26.6M as of Q2 2026.
  • Pictet Asset Management sold 13,392 Viking Therapeutics shares in Q2 2026, an estimated $433K.
  • Viking Therapeutics made up 0.03% of Pictet Asset Management's portfolio in Q2 2026, its #470 holding.
  • Pictet Asset Management first reported a position in Viking Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Viking Therapeutics position peaked at $113M in Q1 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.